Key financial data

Fixed income

At a glance

Gearing ratio
Net debt

End of December 2019: net debt of €15,107 million (gross debt of €24,568 million after derivatives minus €9,427 million cash and cash equivalents)

Net debt is a non GAAP measure
Gearing ratio: Debt, net of cash and cash equivalents, to total equity

€ million 2019 2018
Long-term debt 20,131 22,007
Short-term debt and
current portion of
long-term debt
4,554 2,633
Interest rate and
currency derivatives
used to hedge debt
(117) (54)
Total debt 24,568 24,586
Cash and cash
equivalents
(9,427) (6,925)
Interest rate and
currency derivatives
used to manage cash
and cash equivalents
(34) (33)
Net debt* 15,107 17,628
Total equity 59,108 59,035
Gearing ratio 25.6% 29.9%

*With effect from January 1, 2019, the first-time application of IFRS 16 means that lease liabilities are not included in net debt.

Credit ratings

Credit ratings assess the credit worthiness of the Company and its ability to pay its debt.
Sanofi is followed by three credit rating agencies:

MOODY’S STANDARD &
POOR’S
SCOPE RATINGS
ANALYST Vincent Gusdorf Marketa Horkova Olaf Tolke
SHORT-TERM RATING P-1 A-1+ S-1+
LONG-TERM RATING A1 AA AA
OUTLOOK Stable Negative Stable
LAST UPDATE November 29, 2019 April 25, 2019 September 19, 2019

Debt structure

Gross debt structure at value on redemption as of December 31, 2018

Financing instruments

Public debt programs as of December 31, 2019

EMTN - European Medium Term Note
EMTN program: €25 billion

Implemented in March 10, 2020
SEC Sheld Registered
US SEC Shelf Registered program:
no specific size


Implemented in March 15, 2016
Commercial Papers
Negotiable European Commercial
Papers (NEU CP): €6 billion


Implemented on June 7, 2019
U.S. Commercial Papers: $10 billion
Implemented in December 22, 2004

Syndicated credit lines as of December 31, 2019

SIZE MATURITY
€4 billion December 2020
€4 billion December 2021

Bonds as of December 31, 2019

Bonds Issued by Sanofi S.A

Issuance date Amount
outstanding
(million of
local
currency)
Maturity Coupon ISIN Program
March 29, 2011 USD 2,000 March 29, 2021 4.000% US80105NAG07 SEC Registered
Sept. 4, 2013 EUR 1,000 Sept. 4, 2020 1.875% FR0011560333 EMTN
Nov. 14, 2013 EUR 1,000 Nov. 14, 2023 2.500% FR0011625433 EMTN
Sept. 10, 2014 EUR 1,000 March 10, 2022 1.125% FR0012146777 EMTN
Sept. 10, 2014 EUR 1,510 Sept. 10, 2026 1.750% FR0012146801 EMTN
Sept. 22, 2015 EUR 500 March 22, 2021 0.875% FR0012969020 EMTN
Sept. 22, 2015 EUR 750 March 22, 2025 1.500% FR0012969038 EMTN
April 5, 2016 EUR 600 April 5, 2024 0.625% FR0013143997 EMTN
April 5, 2016 EUR 700 April 5, 2028 1.125% FR0013144003 EMTN
Sept. 13, 2016 EUR 1,000 Jan. 13, 2020 0.000% FR0013201613 EMTN
Sept. 13, 2016 EUR 850 Sept. 13, 2022 0.000% FR0013201621 EMTN
Sept. 13, 2016 EUR 1,150 Jan. 13, 2027 0.500% FR0013201639 EMTN
March 21, 2018 EUR 1000 March 21, 2020 €3m + 15bps FR0013324316 EMTN
March 21, 2018 EUR 500 March 21, 2020 0,000% FR0013324324 EMTN
March 21, 2018 EUR 1750 March 21, 2023 0,500% FR0013324332 EMTN
March 21, 2018 EUR 1500 March 21, 2026 1,000% FR0013324340 EMTN
March 21, 2018 EUR 2000 March 21, 2030 1,375% FR0013324357 EMTN
March 21, 2018 EUR 1250 March 21, 2038 1,875% FR0013324373 EMTN
June 19, 2018 USD 1000 June 19, 2023 3,375% US801060AC87 SEC REGISTERED
June 19, 2018 USD 1000 June 19, 2028 3,625% US801060AD60 SEC REGISTERED
March 21, 2019 EUR 850 March 21, 2022 0.000% FR0013409836 EMTN
March 21, 2019 EUR 650 March 21, 2029 0.875% FR0013409844 EMTN
March 21, 2019 EUR 500 March 21, 2034 1.250% FR0013409851 EMTN
Notes:
  • Private placements are not included in this list
  • Before derivative instruments

Bonds Issued by Other Subsidiaries of the Company

Issuer Date of Issuance Amount
Outstanding
(Million of local
currency)
Maturity Coupon ISIN
Genzyme Corp. June 17, 2010 USD 500 June 15, 2020 5.000% US372917AS37

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK